Drug Discov Ther. 2020;14(3):151-152. (DOI: 10.5582/ddt.2020.03055)
Devoting attention to the management of community-acquired pneumonia for the elderly
Community-acquired pneumonia (CAP) is the third leading contributor to lost disability-adjusted life years worldwide, and this is especially true in the elderly population. In order to reduce the burden of disease, effective management of CAP is crucial to public health in terms of maintaining and promoting the health of the elderly and involves safe drug use, vaccinations, early treatment in the ICU, and health education. Since the long-term mortality of CAP is particularly high in the elderly, biomarkers and a predictive diagnostic model of CAP should be developed in future research.
KEYWORDS: community-acquired pneumonia (CAP), management